PATIENCE DAVID (Chief Financial Officer) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/15/2025ACC: 0001826667-25-000121
Officer· Chief Financial Officer
Since Feb 2026
+490K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
490K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
New position
8/14/2025
0.00→200K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2025 | A · Award | +200K | — | — | New position | 0.00 | 200K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
290K shares
Shares
+290K
Strike price
3.88
Held after
290K
Exercisable
—
8/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock290K shares | 8/14/2025 | A · Award | +290K | 3.88 | — | 290K |